EcoDrugPlus

Carbonic Anhydrase 7-Like

Ensembl ID : ENSPNAG00000008342
Gene Symbol: LOC108443210
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSPNAG00000010021
Gene Symbol: CA4B
1 Cross references
196 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSPNAG00000026439
Gene Symbol: CSNK1E
3 Cross references
205 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSPNAG00000001893
Gene Symbol: LOC108431980
3 Cross references
150 Possible Orthologues:

Caspase 9

Ensembl ID : ENSPNAG00000020640
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSPNAG00000023357
Gene Symbol: LOC108438386
2 Cross references
177 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSPNAG00000024067
Gene Symbol: LOC108440549
3 Cross references
166 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSPNAG00000018256
Gene Symbol: COMT
3 Cross references
211 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSPNAG00000026713
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSPNAG00000002221
Gene Symbol: LOC108441922
3 Cross references
236 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSPNAG00000002203
Gene Symbol: LOC108441923
3 Cross references
235 Possible Orthologues:

Cation Channel Sperm-Associated Protein 1-Like

Ensembl ID : ENSPNAG00000026433
Gene Symbol: LOC108436636
2 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).